The Third International Meeting on Genetic Disorders in the RAS/MAPK Pathway: Toward a Therapeutic Approach

被引:7
|
作者
Korf, Bruce [1 ]
Ahmadian, Reza [2 ]
Allanson, Judith [3 ]
Aoki, Yoko [4 ]
Bakker, Annette [5 ]
Wright, Emma Burkitt [6 ,7 ]
Denger, Brian [8 ]
Elgersma, Ype [9 ]
Gelb, Bruce D. [10 ]
Gripp, Karen W. [11 ]
Kerr, Bronwyn [12 ]
Kontaridis, Maria [13 ,14 ]
Lazaro, Conxi [15 ]
Linardic, Corinne [16 ]
Lozano, Reymundo [17 ]
MacRae, Calum A. [13 ,18 ]
Messiaen, Ludwine [1 ]
Mulero-Navarro, Sonia [10 ]
Neel, Benjamin [19 ]
Plotkin, Scott [20 ]
Rauen, Katherine A. [21 ]
Roberts, Amy [13 ,22 ]
Silva, Alcino J. [23 ]
Sittampalam, Sitta G. [24 ]
Zhang, Chao [25 ]
Schoyer, Lisa [26 ]
机构
[1] Univ Alabama Birmingham, Birmingham, AL USA
[2] Univ Dusseldorf, Dusseldorf, Germany
[3] Childrens Hosp Eastern Ontario, Ottawa, ON K1H 8L1, Canada
[4] Tohoku Univ, Sch Med, Sendai, Miyagi 980, Japan
[5] Childrens Tumor Fdn, New York, NY USA
[6] Manchester Ctr Genom Med, Manchester, Lancs, England
[7] Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England
[8] Parent Project Muscular Dystrophy, Hackensack, NJ USA
[9] Erasmus Univ, NL-3000 DR Rotterdam, Netherlands
[10] Icahn Sch Med Mt Sinai, New York, NY 10029 USA
[11] Alfred I DuPont Hosp Children, Wilmington, NC USA
[12] Manchester Ctr Genom Med, Manchester, Lancs, England
[13] Harvard Univ, Sch Med, Boston, MA USA
[14] Beth Israel Deaconess Med Canc Ctr, Boston, MA USA
[15] Catalan Inst Oncol ICO IDIBELL, Barcelona, Spain
[16] Duke Univ, Sch Med, Durham, NC USA
[17] UC Calif, Davis, CA USA
[18] Brigham & Womens Hosp, Boston, MA 02115 USA
[19] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada
[20] Massachusetts Gen Hosp, Boston, MA 02114 USA
[21] Univ Calif Davis, Davis MIND Inst, Sacramento, CA 95817 USA
[22] Boston Childrens Hosp, Boston, MA USA
[23] Univ Calif Los Angeles, Los Angeles, CA USA
[24] NIH, NCATS, Baltimore, MD USA
[25] Plexxikon Inc, Berkeley, CA USA
[26] RASopathies Network USA, Altadena, CA USA
关键词
Ras; neurofibromatosis; noonan syndrome; costello syndrome; cardio-facio-cutaneous syndrome; NOONAN SYNDROME; GERMLINE MUTATIONS; CANCER; SPECTRUM; GAIN;
D O I
10.1002/ajmg.a.37089
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
"The Third International Meeting on Genetic Disorders in the RAS/MAPK Pathway: Towards a Therapeutic Approach" was held at the Renaissance Orlando at SeaWorld Hotel (August 2-4, 2013). Seventy-one physicians and scientists attended the meeting, and parallel meetings were held by patient advocacy groups (CFC International, Costello Syndrome Family Network, NF Network and Noonan Syndrome Foundation). Parent and patient advocates opened the meeting with a panel discussion to set the stage regarding their hopes and expectations for therapeutic advances. In keeping with the theme on therapeutic development, the sessions followed a progression from description of the phenotype and definition of therapeutic endpoints, to definition of genomic changes, to identification of therapeutic targets in the RAS/MAPK pathway, to preclinical drug development and testing, to clinical trials. These proceedings will review the major points of discussion. (C) 2015 Wiley Periodicals, Inc.
引用
收藏
页码:1741 / 1746
页数:6
相关论文
共 42 条
  • [31] TREATMENT OF NARCISSISTIC AND BORDERLINE DISORDERS IN MARITAL-THERAPY - SUGGESTIONS TOWARD AN ENHANCED THERAPEUTIC APPROACH
    SOLOMON, MF
    CLINICAL SOCIAL WORK JOURNAL, 1985, 13 (02) : 141 - 156
  • [32] Still moving toward automation of the systematic review process: a summary of discussions at the third meeting of the International Collaboration for Automation of Systematic Reviews (ICASR)
    Annette M. O’Connor
    Guy Tsafnat
    Stephen B. Gilbert
    Kristina A. Thayer
    Ian Shemilt
    James Thomas
    Paul Glasziou
    Mary S. Wolfe
    Systematic Reviews, 8
  • [33] Still moving toward automation of the systematic review process: a summary of discussions at the third meeting of the International Collaboration for Automation of Systematic Reviews (ICASR)
    O'Connor, Annette M.
    Tsafnat, Guy
    Gilbert, Stephen B.
    Thayer, Kristina A.
    Shemilt, Ian
    Thomas, James
    Glasziou, Paul
    Wolfe, Mary S.
    SYSTEMATIC REVIEWS, 2019, 8 (1)
  • [34] Combining an integrative genetic approach and therapeutic studies identifies the NFkB pathway as crucial in BRAF mutant melanomas
    Dalla Palma, Maurizia
    Korenblit, Michelle
    Li, Bin
    Hammond, Rachel
    Diskin, Sharon
    Weber, Barbara
    Herlyn, Meenhard
    Smalley, Keiran
    Gimotty, Phyllis
    Nathanson, Katherine
    CANCER RESEARCH, 2009, 69
  • [35] Mutations in the RAS-BRAF-MAPK-ERK pathway define a specific subgroup of patients with adverse clinical features and provide new therapeutic options in chronic lymphocytic leukemia
    Gimenez, Neus
    Martinez-Trillos, Alejandra
    Montraveta, Arnau
    Lopez-Guerra, Monica
    Rosich, Laia
    Nadeu, Ferran
    Valero, Juan G.
    Aymerich, Marta
    Magnano, Laura
    Rozman, Maria
    Matutes, Estella
    Delgado, Julio
    Baumann, Tycho
    Gine, Eva
    Gonzalez, Marcos
    Alcoceba, Miguel
    Jose Terol, M.
    Navarro, Blanca
    Colado, Enrique
    Payer, Angel R.
    Puente, Xose S.
    Lopez-Otin, Carlos
    Lopez-Guillermo, Armando
    Campo, Elias
    Colomer, Dolors
    Villamor, Neus
    HAEMATOLOGICA, 2019, 104 (03) : 576 - 586
  • [36] ERK Inhibitor LY3214996 Targets ERK Pathway-Driven Cancers: A Therapeutic Approach Toward Precision Medicine
    Bhagwat, Shripad V.
    McMillen, William T.
    Cai, Shufen
    Zhao, Baohui
    Whitesell, Matthew
    Shen, Weihua
    Kindler, Lisa
    Flack, Robert S.
    Wu, Wenjuan
    Anderson, Bryan
    Zhai, Yan
    Yuan, Xiu-Juan
    Pogue, Meghann
    Van Horn, Robert D.
    Rao, Xi
    McCann, Denis
    Dropsey, Andrew J.
    Manro, Jason
    Walgren, Jennie
    Yuen, Eunice
    Rodriguez, Michael J.
    Plowman, Gregory D.
    Tiu, Ramon V.
    Joseph, Sajan
    Peng, Sheng-Bin
    MOLECULAR CANCER THERAPEUTICS, 2020, 19 (02) : 325 - 336
  • [37] Marine genetic resources as common heritage of mankind under the BBNJ Agreement; the international community toward a pragmatic benefit-sharing approach?
    Taghizadeh, Zakieh
    BIODIVERSITY AND CONSERVATION, 2025, 34 (01) : 131 - 153
  • [38] Diagnosis of comorbid migraine without aura in patients with idiopathic/genetic epilepsy based on the gray zone approach to the International Classification of Headache Disorders 3 criteria
    Atalar, Arife Cimen
    Ozge, Aynur
    Turk, Bengi Gul
    Ekizoglu, Esme
    Gok, Duygu Kurt
    Baykan, Betul
    Ayta, Semih
    Erdogan, Fusun Ferda
    Yeni, Seher Naz
    Tasdelen, Bahar
    Velioglu, Sibel K.
    FRONTIERS IN NEUROLOGY, 2023, 13
  • [39] Somatic mutation of genes impacting on the RAS-RAF-MEK-ERK pathway is the most common genetic abnormality in childhood acute lymphoblastic leukaemia, is implicated in disease progression and provides a rationale for therapeutic targeting
    Case, M.
    Matheson, E.
    Minto, L.
    Hassan, R.
    Harrison, C.
    Bown, N.
    Bailey, S.
    Vormoor, J.
    Hall, A.
    Irving, J.
    BRITISH JOURNAL OF HAEMATOLOGY, 2008, 141 : 5 - 5
  • [40] Decoding intrathecal immunoglobulins and B cells in the CNS: their synthesis, function, and regulation Modulation of immune responses mediated by different B cells is a potential therapeutic approach toward ameliorating several CNS disorders
    Negi, Neema
    Das, Bimal K.
    INTERNATIONAL REVIEWS OF IMMUNOLOGY, 2020, 39 (02) : 67 - 79